日本全国COVID-19数据库研究:机械通气COVID-19患者年龄与死亡率的关系
该研究利用日本COVID-19登记数据库(2020年1月1日至2021年2月28日登记的33808例中1555例接受有创机械通气者),评估年龄与COVID-19相关死亡率的关系。按年龄组死亡率分别为50多岁8.6%、60多岁20.7%、70多岁34.9%、80多岁49.7%、90多岁83.3%。多因素分析(广义估计方程,校正院内聚集、合并症、激素使用、COVID-19用药及入院生命体征)显示,与<60岁相比,60多岁、70多岁、80多岁、90多岁死亡OR分别为2.6(1.6-4.1)、6.9(4.2-11.3)、13.2(7.2-24.1)、92.6(16.7-515.0)。作者认为年龄对接受IMV的COVID-19患者死亡率影响很大,防止高龄患者进展为重症可能是重要公共卫生问题。
要点
- 接受有创机械通气的COVID-19患者中,死亡率随年龄增长而升高:50多岁8.6%、60多岁20.7%、70多岁34.9%、80多岁49.7%、90多岁83.3%。
- 校正合并症、激素使用、COVID-19用药及入院生命体征后,与<60岁相比,60多岁死亡OR 2.6(1.6-4.1)、70多岁6.9(4.2-11.3)、80多岁13.2(7.2-24.1)、90多岁92.6(16.7-515.0)。
- 90多岁组死亡OR的95%CI为16.7-515.0,上限极宽,提示该组样本量有限、估计不精确。
- 作者认为年龄与接受IMV的COVID-19患者更高死亡率相关,防止高龄患者进展为重症可能是重要公共卫生问题。
适用人群与场景
- 日本COVID-19登记数据库中实验室确诊COVID-19并接受有创机械通气的住院患者1555例(2020年1月1日至2021年2月28日登记的33808例中)。
研究设计与关键结果
- 研究类型:基于日本COVID-19登记数据库的全国多中心队列研究。
- 样本量:33808例登记患者中分析1555例接受有创机械通气者。
- 按年龄组死亡率:50多岁8.6%、60多岁20.7%、70多岁34.9%、80多岁49.7%、90多岁83.3%。
- 多因素分析(广义估计方程,校正院内聚集、合并症、激素使用、COVID-19用药及入院生命体征)显示,与<60岁相比,60多岁、70多岁、80多岁、90多岁死亡OR分别为2.6(1.6-4.1)、6.9(4.2-11.3)、13.2(7.2-24.1)、92.6(16.7-515.0)。
证据类型、等级与局限
- 证据类型:全国多中心队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为年龄与接受有创机械通气的COVID-19患者更高死亡率相关,防止高龄患者进展为重症可能是重要公共卫生问题。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Only a few studies have reported the association between age and mortality in COVID-19 patients who require invasive mechanical ventilation (IMV). We aimed to evaluate the effect of age on COVID-19-related mortality among patients undergoing IMV therapy.
METHODS: This cohort study was conducted using the COVID-19 Registry Japan database, a nationwide multi-centre study of hospitalized patients with laboratory-confirmed COVID-19. Of all 33,808 cases registered between 1 January 2020 to 28 February 2021, we analysed 1555 patients who had undergone IMV. We evaluated mortality rates between age groups using multivariable regression analysis after adjusting for known potential components, such as within-hospital clustering, comorbidities, steroid use, medication for COVID-19, and vital signs on admission, using generalized estimation equation.
RESULTS: By age group, the mortality rates in the IMV group were 8.6%, 20.7%, 34.9%, 49.7% and 83.3% for patients in their 50s, 60s, 70s, 80s, and 90s, respectively. Multivariable analysis showed that compared with those for patients aged < 60 years, the odds ratios (95% confidence interval) of death were 2.6 (1.6-4.1), 6.9 (4.2-11.3), 13.2 (7.2-24.1), 92.6 (16.7-515.0) for patients in their 60s, 70s, 80s, and 90s, respectively.
CONCLUSIONS: In this cohort study, age had a great effect on mortality in COVID-19 patients undergoing IMV, after adjusting for variables independently associated with mortality. This study suggested that age was associated with higher mortality and that preventing progression to severe COVID-19 in elderly patients may be a great public health issue.
参考来源
- Tanaka C, Tagami T, Nakayama F, et al. Association between mortality and age among mechanically ventilated COVID-19 patients: a Japanese nationwide COVID-19 database study. Ann Intensive Care. 2021. PMID: 34897587. doi:10.1186/s13613-021-00959-6
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。